We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fusion Antibodies Plc | LSE:FAB | London | Ordinary Share | GB00BDQZGK16 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.45% | 3.40 | 3.30 | 3.50 | 3.45 | 3.40 | 3.45 | 337,987 | 14:17:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.9M | -2.6M | -0.0437 | -0.78 | 2.02M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/4/2024 15:00 | Just read your last 10 posts, another bot for the filter bin... | troutisout | |
02/4/2024 14:56 | Yep fab considering delisting needs shareholder vote to agree | beatme1 | |
02/4/2024 10:31 | They do not have billions of shares | bobaxe1 | |
02/4/2024 09:51 | Bought APH , Alliance Pharma plc , growing profitable health care company | blackhorse23 | |
02/4/2024 08:38 | Hearing fab want to delist following other pharma stocks | beatme1 | |
22/3/2024 18:56 | I agree I bought at 3.73Fully funded and ready for a re-rate | bigjock36 | |
22/3/2024 14:48 | No brainier down here | bobaxe1 | |
21/3/2024 13:36 | According to the financials we have 10x cash to Mcap surly that is not so ? | bobaxe1 | |
15/3/2024 16:03 | Just topped up shows red good price not complaining | bobaxe1 | |
14/3/2024 13:22 | https://x.com/fsnant | bobaxe1 | |
07/3/2024 12:19 | Looking good, I think they want to take it higher | soultrading | |
07/3/2024 08:37 | Picking up here | bobaxe1 | |
05/3/2024 15:36 | Decent 901k buy there ?? | bigjock36 | |
03/3/2024 21:16 | Some decent news after placing and 7 should not be an issue | bigjock36 | |
01/3/2024 11:19 | Nice to see a bit of action back, another assault on 7s please, GLA | lawson27 | |
01/3/2024 11:02 | I have, but have been several of the larger buys since last Thursday last week, so been happy with the way the price action has gone... | troutisout | |
01/3/2024 09:14 | Anyone else noticed a regular pattern with this. An immediate sell of a few thousand at the start of the day to weaken the price, and then multiple larger buys throughout the day | ksddw2 | |
27/2/2024 12:33 | Agree soultrading-cash roughly 60% of market cap and little snippets, like this am's deal, small as it is, all help and happy to see them them getting a few more over the next year so they can gain traction within the field. What is important here is not the amount but the fact a tiny Belfast company's antibody library is even sufficiently worthwhile that a global diagnostics company, and the US NCI would even be aware of it. The science must be OK-all it takes is one tiny break....but they will be snapped up soon imo. | cumnor | |
27/2/2024 11:23 | Probably the best time to buy for a while. Funded with anticipated news flow makes the current cap look like an opportunity.Once the placees get their shares we can expect a real ramp. As shard did the book build we can add 6% on to 4p just for their break even price and I bet they want a lot more, as I am aware a chunk are sticky.Director options are 4.25 which implies that they believe the price will be way north of that.Those new or reinvesting have an opportunity to get in at a decent level and with funding sorted it eliminates some risk. | soultrading | |
27/2/2024 10:31 | "Fusion Antibodies (FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announced it has received a first purchase order under the master services agreement (MSA) with a leading diagnostics company details of which were announced on 14 February 2024. FAB said reaching this agreement with a world class diagnostics provider positively reinforces the value to the wider commercial world of Fusion Antibodies’ technologies and capabilities. In this case it is the generation of antibodies in diagnostics products. Comment: It could be argued that fundamentally FAB is now on track as a recovery situation, with the purchase order and recent funding. Only a rise in the share price is missing." | troutisout | |
15/2/2024 14:27 | behave abbeygale ! prior to the placing their was less shares in issue & Granted with volume the Sp marched North, so now the prospects of more shares in issue weakens the "Eps ! giving a lower share value & a realistic value Due South....The Law of Gravity ?...Every day is a School Day ! | dreamtwister | |
15/2/2024 14:01 | I have not fallen for the selling this time round. As I know how quickly it goes back up. | luckyabbeygale | |
15/2/2024 10:06 | Latest broker note hxxps://wp-allenby-2 | gtc1508 | |
14/2/2024 13:13 | i notice abbey has got her grannie Knickers on ....lol...(y) | dreamtwister |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions